Article Text

Download PDFPDF
557 Double hepatic segmentectomy assisted with ICG for recurrence of ovarian cancer
  1. Sergi Fernandez-Gonzalez1,
  2. Juan Carlos Torrejon-Becerra1,
  3. Marc Barahona1,
  4. Ana Maria Muñoz1,
  5. Yolanda Perez1,
  6. Kristel Mils1,
  7. Laura Lladó1,
  8. Edu Dorca1,
  9. August Vidal1,
  10. Xavier Matias-Guiu1,
  11. Ana Sánchez1,
  12. Pilar Perlaza1,
  13. Dina Najjari2,
  14. Milica Stefanovic2,
  15. Bea Pardo2,
  16. Marta Gil2,
  17. Lola Martí1 and
  18. Jordi Ponce1
  1. 1Bellvitge University Hospital, Barcelona, Spain
  2. 2Institut Català d’Oncologia, Barcelona, Spain


Introduction/Background Despite the development of new targeted therapies for patients with ovarian cancer, surgery remains a fundamental cornerstone in its treatment, particularly in the management of recurrences. Our objective is to present a highly complex surgical case managed multidisciplinary, from the surgical indication to postoperative care.

Methodology A 61-year-old patient was suspected of ovarian recurrence with 21 months of disease-free survival after completing her first-line treatment of NACT+IDS+Adjuvant chemotherapy (CBDCA AUC 6 + TAXOL 175mg/m2) + iPARP maintenance due to advanced stage high-grade serous ovarian cancer. HRD: BRCA1.

In PET/CT, a 25mm lesion with SUV max 9.87 was observed in segments IV-V of the liver, in contact with the hepatic ilium and cava vein. A second hypermetabolic lesion was identified in segment IV without morphologic translation. Retrocaval lymph node metastasis was also reported. The multidisciplinary tumor board considered the patient for a secondary cytoreduction due to high probabilities of complete cytoreductive surgery. Double hepatic segmentectomy assisted with ICG was performed and recorded by an open approach in 320min with an estimated blood loss of 350ml (Paraaortic cytoreduction was also performed, not recorded).

Results The patient was discharged four days after surgery and Clavien-Dindo II wound seroma was recorded postoperatively. Pathological results confirmed HGSC in both liver resections and para-aortic lymphadenectomy.

Conclusion Recurrences with high surgical risk are common in patients with advanced ovarian cancer. Complete resection may be feasible in some cases, with a benefit in overall survival. Multidisciplinary management is essential in the effort for disease chronification, considering quality of life.

Disclosures No.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.